These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28817974)

  • 1. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies.
    Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I
    Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease.
    Da Silva Correia SM; Schmitz M; Fischer A; Hermann P; Zerr I
    Cell Tissue Res; 2023 Apr; 392(1):301-306. PubMed ID: 36536226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and Detection of Minuscule Amounts of Misfolded Prion Protein by Using the Real-Time Quaking-Induced Conversion.
    Schmitz M; Candelise N; Llorens F; Zerr I
    Methods Mol Biol; 2018; 1779():257-263. PubMed ID: 29886538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases.
    Schmitz M; Cramm M; Llorens F; Müller-Cramm D; Collins S; Atarashi R; Satoh K; Orrù CD; Groveman BR; Zafar S; Schulz-Schaeffer WJ; Caughey B; Zerr I
    Nat Protoc; 2016 Nov; 11(11):2233-2242. PubMed ID: 27735933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.
    Singh S; DeMarco ML
    J Appl Lab Med; 2020 Jan; 5(1):142-157. PubMed ID: 31811072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplified Detection of Prions and Other Amyloids by RT-QuIC in Diagnostics and the Evaluation of Therapeutics and Disinfectants.
    Caughey B; Orru CD; Groveman BR; Hughson AG; Manca M; Raymond LD; Raymond GJ; Race B; Saijo E; Kraus A
    Prog Mol Biol Transl Sci; 2017; 150():375-388. PubMed ID: 28838670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of prion infectivity in tissues and body fluids by real-time quaking-induced conversion.
    Henderson DM; Davenport KA; Haley NJ; Denkers ND; Mathiason CK; Hoover EA
    J Gen Virol; 2015 Jan; 96(Pt 1):210-219. PubMed ID: 25304654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free prion protein conversion assays in screening for anti-prion drug candidates.
    do Carmo Ferreira N; Caughey B
    Curr Opin Pharmacol; 2019 Feb; 44():1-7. PubMed ID: 30412823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
    Zhang W; Orrú CD; Foutz A; Ding M; Yuan J; Shah SZA; Zhang J; Kotobelli K; Gerasimenko M; Gilliland T; Chen W; Tang M; Cohen M; Safar J; Xu B; Hong DJ; Cui L; Hughson AG; Schonberger LB; Tatsuoka C; Chen SG; Greenlee JJ; Wang Z; Appleby BS; Caughey B; Zou WQ
    Acta Neuropathol; 2024 Jan; 147(1):17. PubMed ID: 38231266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
    Saá P; Cervenakova L
    Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel screening approaches for human prion diseases drug discovery.
    Moda F; Bolognesi ML; Legname G
    Expert Opin Drug Discov; 2019 Oct; 14(10):983-993. PubMed ID: 31271065
    [No Abstract]   [Full Text] [Related]  

  • 14. Amplification Techniques for the Detection of Misfolded Prion Proteins in Experimental and Clinical Samples.
    Haley N
    Curr Protoc Mol Biol; 2020 Mar; 130(1):e118. PubMed ID: 32150353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion.
    Kang HE; Mo Y; Abd Rahim R; Lee HM; Ryou C
    Biomed Res Int; 2017; 2017():5413936. PubMed ID: 28596963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie.
    Schmitz M; Cramm M; Llorens F; Candelise N; Müller-Cramm D; Varges D; Schulz-Schaeffer WJ; Zafar S; Zerr I
    Sci Rep; 2016 Jul; 6():28711. PubMed ID: 27385410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
    Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
    Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Misfolding Cyclic Amplification of Infectious Prions.
    Moda F
    Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification techniques and diagnosis of prion diseases.
    Brandel JP; Culeux A; Grznarova K; Levavasseur E; Lamy P; Privat N; Welaratne A; Denouel A; Laplanche JL; Haik S
    Rev Neurol (Paris); 2019; 175(7-8):458-463. PubMed ID: 31296398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, implementation, and interpretation of amplification studies for prion detection.
    Haley NJ; Richt JA; Davenport KA; Henderson DM; Hoover EA; Manca M; Caughey B; Marthaler D; Bartz J; Gilch S
    Prion; 2018 Mar; 12(2):73-82. PubMed ID: 29468946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.